Advancements in Viral Vector Manufacturing: Platform Development, Critical Starting Material Selection, and Insights into AAV and Adenovirus Production

Tuesday, March 19, 2024 at 4:10 PM to 4:30 PM · 20 min. (Europe/London)
Viral Vector Manufacturing [Track 9]
Presentation
Exothera
7
Exothera is a contract, development, and manufacturing organization (CDMO) dedicated to viral vector and nucleic acids production. As a technology-driven company, Exothera provides best-in-class bioprocessing expertise that capitalizes on the best and most innovative manufacturing technologies developed within the Univercells group. The company delivers accelerated discovery services as well as process development/optimization to rapidly reach GMP clinical and commercial production of vaccines, viral vectors, and nucleic acids. At Exothera and Univercells, our mission is to make life-changing therapies available to all. For more information, visit www.exothera.world.

Registered attendees

Alexandra Harrison
Alexandra Harrison
PhD StudentUniversity of Bristol
imen mestiri
imen mestiri
Business Development LeadGenethon
RL
Roel Lievrouw
Downstream Process Development ManagerExothera SA

Log in

See all the content and easy-to-use features by logging in or registering!